PMCCPMCCPMCC

Search tips
Search criteria 

Advanced

 
Logo of jcinvestThe Journal of Clinical InvestigationCurrent IssueArchiveSubscriptionAbout the Journal
 
J Clin Invest. 1991 August; 88(2): 561–570.
PMCID: PMC295386

Effect of physiologic hyperinsulinemia on glucose and lipid metabolism in cirrhosis.

Abstract

Insulin secretion and insulin sensitivity were evaluated in eight clinically stable cirrhotic patients and in 12 controls. OGTT was normal in cirrhotics but plasma insulin response was increased approximately twofold compared with controls. Subjects received a three-step (0.1, 0.5, 1.0 mU/kg.min) euglycemic insulin clamp with indirect calorimetry, [6-3H]-glucose, and [1-14C]-palmitate. During the two highest insulin infusion steps glucose uptake was impaired (3.33 +/- 0.31 vs. 5.06 +/- 0.40 mg/kg.min, P less than 0.01, and 6.09 +/- 0.50 vs. 7.95 +/- 0.52 mg/kg.min, P less than 0.01). Stimulation of glucose oxidation by insulin was normal; in contrast, nonoxidative glucose disposal (i.e., glycogen synthesis) was markedly reduced. Fasting (r = -0.553, P less than 0.01) and glucose-stimulated (r = -0.592, P less than 0.01) plasma insulin concentration correlated inversely with the severity of insulin resistance. Basal hepatic glucose production was normal in cirrhotics and suppressed normally with insulin. In postabsorptive state, plasma FFA conc (933 +/- 42 vs. 711 +/- 44 mumol/liter, P less than 0.01) and FFA turnover (9.08 +/- 1.20 vs. 6.03 +/- 0.53 mumol/kg.min, P less than 0.01) were elevated in cirrhotics despite basal hyperinsulinemia; basal FFA oxidation was similar in cirrhotic and control subjects. With low-dose insulin infusion, plasma FFA oxidation and turnover failed to suppress normally in cirrhotics. During the two higher insulin infusion steps, all parameters of FFA metabolism suppressed normally. In summary, stable cirrhotic patients with normal glucose tolerance exhibit marked insulin resistance secondary to the impaired nonoxidative glucose disposal. Our results suggest that chronic hyperinsulinism may be responsible for the insulin resistance observed in cirrhosis.

Full text

Full text is available as a scanned copy of the original print version. Get a printable copy (PDF file) of the complete article (2.4M), or click on a page image below to browse page by page. Links to PubMed are also available for Selected References.

Selected References

These references are in PubMed. This may not be the complete list of references from this article.
  • Megyesi C, Samols E, Marks V. Glucose tolerance and diabetes in chronic liver disease. Lancet. 1967 Nov 18;2(7525):1051–1056. [PubMed]
  • Creutzfeldt W, Frerichs H, Sickinger K. Liver diseases and diabetes mellitus. Prog Liver Dis. 1970;3:371–407. [PubMed]
  • Johnson DG, Alberti KG, Faber OK, Binder C. Hyperinsulinism of hepatic cirrhosis: Diminished degradation or hypersecretion? Lancet. 1977 Jan 1;1(8001):10–13. [PubMed]
  • Proietto J, Dudley FJ, Aitken P, Alford FP. Hyperinsulinaemia and insulin resistance of cirrhosis: the importance of insulin hypersecretion. Clin Endocrinol (Oxf) 1984 Dec;21(6):657–665. [PubMed]
  • Proietto J, Nankervis A, Aitken P, Dudley FJ, Caruso G, Alford FP. Insulin resistance in cirrhosis: evidence for a post-receptor defect. Clin Endocrinol (Oxf) 1984 Dec;21(6):677–688. [PubMed]
  • Taylor R, Heine RJ, Collins J, James OF, Alberti KG. Insulin action in cirrhosis. Hepatology. 1985 Jan-Feb;5(1):64–71. [PubMed]
  • Cavallo-Perin P, Cassader M, Bozzo C, Bruno A, Nuccio P, Dall'Omo AM, Marucci M, Pagano G. Mechanism of insulin resistance in human liver cirrhosis. Evidence of a combined receptor and postreceptor defect. J Clin Invest. 1985 May;75(5):1659–1665. [PMC free article] [PubMed]
  • Iversen J, Vilstrup H, Tygstrup N. Kinetics of glucose metabolism in relation to insulin concentrations in patients with alcoholic cirrhosis and in healthy persons. Gastroenterology. 1984 Nov;87(5):1138–1143. [PubMed]
  • DeFronzo RA, Jacot E, Jequier E, Maeder E, Wahren J, Felber JP. The effect of insulin on the disposal of intravenous glucose. Results from indirect calorimetry and hepatic and femoral venous catheterization. Diabetes. 1981 Dec;30(12):1000–1007. [PubMed]
  • DeFronzo RA, Ferrannini E. Regulation of hepatic glucose metabolism in humans. Diabetes Metab Rev. 1987 Apr;3(2):415–459. [PubMed]
  • Proietto J, Alford FP, Dudley FJ. The mechanism of the carbohydrate intolerance of cirrhosis. J Clin Endocrinol Metab. 1980 Nov;51(5):1030–1036. [PubMed]
  • RANDLE PJ, GARLAND PB, HALES CN, NEWSHOLME EA. The glucose fatty-acid cycle. Its role in insulin sensitivity and the metabolic disturbances of diabetes mellitus. Lancet. 1963 Apr 13;1(7285):785–789. [PubMed]
  • Owen OE, Trapp VE, Reichard GA, Jr, Mozzoli MA, Moctezuma J, Paul P, Skutches CL, Boden G. Nature and quantity of fuels consumed in patients with alcoholic cirrhosis. J Clin Invest. 1983 Nov;72(5):1821–1832. [PMC free article] [PubMed]
  • Riggio O, Merli M, Cantafora A, Di Biase A, Lalloni L, Leonetti F, Miazzo P, Rinaldi V, Rossi-Fanelli F, Tamburrano G, et al. Total and individual free fatty acid concentrations in liver cirrhosis. Metabolism. 1984 Jul;33(7):646–651. [PubMed]
  • Gunnlaugsson O, Berkowitz D. Individual free fatty acids in patients with liver disease. Am J Dig Dis. 1977 Nov;22(11):1005–1009. [PubMed]
  • DeFronzo RA, Tobin JD, Andres R. Glucose clamp technique: a method for quantifying insulin secretion and resistance. Am J Physiol. 1979 Sep;237(3):E214–E223. [PubMed]
  • HALES CN, RANDLE PJ. Immunoassay of insulin with insulin-antibody precipitate. Biochem J. 1963 Jul;88:137–146. [PubMed]
  • Passon PG, Peuler JD. A simplified radiometric assay for plasma norepinephrine and epinephrine. Anal Biochem. 1973 Feb;51(2):618–631. [PubMed]
  • Miles J, Glasscock R, Aikens J, Gerich J, Haymond M. A microfluorometric method for the determination of free fatty acids in plasma. J Lipid Res. 1983 Jan;24(1):96–99. [PubMed]
  • STEELE R. Influences of glucose loading and of injected insulin on hepatic glucose output. Ann N Y Acad Sci. 1959 Sep 25;82:420–430. [PubMed]
  • Cowan JS, Hetenyi G., Jr Glucoregulatory responses in normal and diabetic dogs recorded by a new tracer method. Metabolism. 1971 Apr;20(4):360–372. [PubMed]
  • Groop LC, Bonadonna RC, DelPrato S, Ratheiser K, Zyck K, Ferrannini E, DeFronzo RA. Glucose and free fatty acid metabolism in non-insulin-dependent diabetes mellitus. Evidence for multiple sites of insulin resistance. J Clin Invest. 1989 Jul;84(1):205–213. [PMC free article] [PubMed]
  • Ferrannini E. The theoretical bases of indirect calorimetry: a review. Metabolism. 1988 Mar;37(3):287–301. [PubMed]
  • Hagenfeldt L, Wahren J, Pernow B, Räf L. Uptake of individual free fatty acids by skeletal muscle and liver in man. J Clin Invest. 1972 Sep;51(9):2324–2330. [PMC free article] [PubMed]
  • Spitzer JJ, Gold M. Studies on the metabolism of free fatty acids in diabetic and fasting dogs. Ann N Y Acad Sci. 1965 Oct 8;131(1):235–249. [PubMed]
  • Issekutz B, Jr, Paul P, Miller HI, Bortz WM. Oxidation of plasma FFA in lean and obese humans. Metabolism. 1968 Jan;17(1):62–73. [PubMed]
  • Cobelli C, Mari A, Ferrannini E. Non-steady state: error analysis of Steele's model and developments for glucose kinetics. Am J Physiol. 1987 May;252(5 Pt 1):E679–E689. [PubMed]
  • Waterhouse C, Baker N, Rostami H. Effect of glucose ingestion on the metabolism of free fatty acids in human subjects. J Lipid Res. 1969 Sep;10(5):487–494. [PubMed]
  • ANDERSON EC. THREE-COMPONENT BODY COMPOSITION ANALYSIS BASED ON POTASSIUM AND WATER DETERMINATIONS. Ann N Y Acad Sci. 1963 Sep 26;110:189–212. [PubMed]
  • Owen OE, Reichle FA, Mozzoli MA, Kreulen T, Patel MS, Elfenbein IB, Golsorkhi M, Chang KH, Rao NS, Sue HS, et al. Hepatic, gut, and renal substrate flux rates in patients with hepatic cirrhosis. J Clin Invest. 1981 Jul;68(1):240–252. [PMC free article] [PubMed]
  • DeFronzo RA. Lilly lecture 1987. The triumvirate: beta-cell, muscle, liver. A collusion responsible for NIDDM. Diabetes. 1988 Jun;37(6):667–687. [PubMed]
  • Butler PC, Kryshak EJ, Schwenk WF, Haymond MW, Rizza RA. Hepatic and extrahepatic responses to insulin in NIDDM and nondiabetic humans. Assessment in absence of artifact introduced by tritiated nonglucose contaminants. Diabetes. 1990 Feb;39(2):217–225. [PubMed]
  • Bell PM, Firth RG, Rizza RA. Assessment of insulin action in insulin-dependent diabetes mellitus using [6(14)C]glucose, [3(3)H]glucose, and [2(3)H]glucose. Differences in the apparent pattern of insulin resistance depending on the isotope used. J Clin Invest. 1986 Dec;78(6):1479–1486. [PMC free article] [PubMed]
  • Ferrannini E, Smith JD, Cobelli C, Toffolo G, Pilo A, DeFronzo RA. Effect of insulin on the distribution and disposition of glucose in man. J Clin Invest. 1985 Jul;76(1):357–364. [PMC free article] [PubMed]
  • Finegood DT, Bergman RN, Vranic M. Estimation of endogenous glucose production during hyperinsulinemic-euglycemic glucose clamps. Comparison of unlabeled and labeled exogenous glucose infusates. Diabetes. 1987 Aug;36(8):914–924. [PubMed]
  • Molina JM, Baron AD, Edelman SV, Brechtel G, Wallace P, Olefsky JM. Use of a variable tracer infusion method to determine glucose turnover in humans. Am J Physiol. 1990 Jan;258(1 Pt 1):E16–E23. [PubMed]
  • Koivisto VA, Yki-Järvinen H, Puhakainen I, Virkamäki A, Kolaczynski J, DeFronzo R. No evidence for isotope discrimination of tritiated glucose tracers in measurements of glucose turnover rates in man. Diabetologia. 1990 Mar;33(3):168–173. [PubMed]
  • Bosch J, Gomis R, Kravetz D, Casamitjana R, Terés J, Rivera F, Rodés J. Role of spontaneous portal-systemic shunting in hyperinsulinism of cirrhosis. Am J Physiol. 1984 Sep;247(3 Pt 1):G206–G212. [PubMed]
  • Nygren A, Adner N, Sundblad L, Wiechel KL. Insulin uptake by the human alcoholic cirrhotic liver. Metabolism. 1985 Jan;34(1):48–52. [PubMed]
  • DeFronzo RA, Ferrannini E, Hendler R, Felig P, Wahren J. Regulation of splanchnic and peripheral glucose uptake by insulin and hyperglycemia in man. Diabetes. 1983 Jan;32(1):35–45. [PubMed]
  • DeFronzo RA, Ferrannini E. Regulation of hepatic glucose metabolism in humans. Diabetes Metab Rev. 1987 Apr;3(2):415–459. [PubMed]
  • Cherrington AD, Stevenson RW, Steiner KE, Davis MA, Myers SR, Adkins BA, Abumrad NN, Williams PE. Insulin, glucagon, and glucose as regulators of hepatic glucose uptake and production in vivo. Diabetes Metab Rev. 1987 Jan;3(1):307–332. [PubMed]
  • Björntorp P, Sjöström L. Carbohydrate storage in man: speculations and some quantitative considerations. Metabolism. 1978 Dec;27(12 Suppl 2):1853–1865. [PubMed]
  • Björntorp P, Berchtold P, Holm J, Larsson B. The glucose uptake of human adipose tissue in obesity. Eur J Clin Invest. 1971 Sep;1(6):480–485. [PubMed]
  • Shulman GI, Rothman DL, Jue T, Stein P, DeFronzo RA, Shulman RG. Quantitation of muscle glycogen synthesis in normal subjects and subjects with non-insulin-dependent diabetes by 13C nuclear magnetic resonance spectroscopy. N Engl J Med. 1990 Jan 25;322(4):223–228. [PubMed]
  • Kruszynska Y, Williams N, Perry M, Home P. The relationship between insulin sensitivity and skeletal muscle enzyme activities in hepatic cirrhosis. Hepatology. 1988 Nov-Dec;8(6):1615–1619. [PubMed]
  • Sherwin R, Joshi P, Hendler R, Felig P, Conn HO. Hyperglucagonemia in Laennec's cirrhosis. The role of portal-systemic shunting. N Engl J Med. 1974 Jan 31;290(5):239–242. [PubMed]
  • Samaan NA, Stone DB, Eckhardt RD. Serum glucose, insulin, and growth hormone in chronic hepatic cirrhosis. Arch Intern Med. 1969 Aug;124(2):149–152. [PubMed]
  • Krauns P, Ruge W. Plasmakatecholaminspiegel bei Lebererkrankungen. Z Gastroenterol. 1985 Feb;23(2):64–73. [PubMed]
  • Thiébaud D, DeFronzo RA, Jacot E, Golay A, Acheson K, Maeder E, Jéquier E, Felber JP. Effect of long chain triglyceride infusion on glucose metabolism in man. Metabolism. 1982 Nov;31(11):1128–1136. [PubMed]
  • Ferrannini E, Barrett EJ, Bevilacqua S, DeFronzo RA. Effect of fatty acids on glucose production and utilization in man. J Clin Invest. 1983 Nov;72(5):1737–1747. [PMC free article] [PubMed]
  • Balasse EO, Neef MA. Operation of the "glucose-fatty acid cycle" during experimental elevations of plasma free fatty acid levels in man. Eur J Clin Invest. 1974 Aug;4(4):247–252. [PubMed]
  • Meylan M, Henny C, Temler E, Jéquier E, Felber JP. Metabolic factors in the insulin resistance in human obesity. Metabolism. 1987 Mar;36(3):256–261. [PubMed]
  • Bevilacqua S, Buzzigoli G, Bonadonna R, Brandi LS, Oleggini M, Boni C, Geloni M, Ferrannini E. Operation of Randle's cycle in patients with NIDDM. Diabetes. 1990 Mar;39(3):383–389. [PubMed]
  • Bonadonna RC, Groop LC, Zych K, Shank M, DeFronzo RA. Dose-dependent effect of insulin on plasma free fatty acid turnover and oxidation in humans. Am J Physiol. 1990 Nov;259(5 Pt 1):E736–E750. [PubMed]
  • Merli M, Eriksson LS, Hagenfeldt L, Wahren J. Splanchnic and leg exchange of free fatty acids in patients with liver cirrhosis. J Hepatol. 1986;3(3):348–355. [PubMed]
  • Fain JN, Garcĩa-Sáinz JA. Adrenergic regulation of adipocyte metabolism. J Lipid Res. 1983 Aug;24(8):945–966. [PubMed]
  • Wahrenberg H, Engfeldt P, Bolinder J, Arner P. Acute adaptation in adrenergic control of lipolysis during physical exercise in humans. Am J Physiol. 1987 Oct;253(4 Pt 1):E383–E390. [PubMed]
  • Deibert DC, DeFronzo RA. Epinephrine-induced insulin resistance in man. J Clin Invest. 1980 Mar;65(3):717–721. [PMC free article] [PubMed]
  • Bratusch-Marrain PR, Smith D, DeFronzo RA. The effect of growth hormone on glucose metabolism and insulin secretion in man. J Clin Endocrinol Metab. 1982 Nov;55(5):973–982. [PubMed]
  • Del Prato S, Castellino P, Simonson DC, DeFronzo RA. Hyperglucagonemia and insulin-mediated glucose metabolism. J Clin Invest. 1987 Feb;79(2):547–556. [PMC free article] [PubMed]
  • Rizza RA, Mandarino LJ, Genest J, Baker BA, Gerich JE. Production of insulin resistance by hyperinsulinaemia in man. Diabetologia. 1985 Feb;28(2):70–75. [PubMed]
  • Petrides AS, DeFronzo RA. Glucose metabolism in cirrhosis: a review with some perspectives for the future. Diabetes Metab Rev. 1989 Dec;5(8):691–709. [PubMed]

Articles from The Journal of Clinical Investigation are provided here courtesy of American Society for Clinical Investigation